Evidence map›Paper›PMID 32274385›Full record

ArticleFrontiers in cell and developmental biology2020

Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells.

Sabena M Conley, LaTonya J Hickson, Todd A Kellogg, Travis McKenzie, Julie K Heimbach, Timucin Taner, Hui Tang, Kyra L Jordan, Ishran M Saadiq, John R Woollard and 5 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cancer-Associated Cachexia in the Era of Obesity.International journal of molecular sciences · 2025
    Review
  19. Is Adipose Tissue Inflammation the Culprit of Obesity-Associated Comorbidities?Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sabena M ConleyDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
LaTonya J HicksonDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Todd A KelloggDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Travis McKenzieDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Julie K HeimbachDepartment of Surgery, Mayo Clinic, Rochester, MN, United States.
Timucin TanerDivision of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Hui TangDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Kyra L JordanDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Ishran M SaadiqDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
John R WoollardDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Busra IsikDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Mohsen AfaridehDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Tamar TchkoniaRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States.
James L KirklandDivision of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Lilach O LermanDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.

Funding

Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Diana Jurk · 2019 to 2026
$28.7M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
KIDNEY DISEASES RESEARCH TRAINING PROGRAMT32DK007013 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 1986 to 2023
$3.7M
MSC-derived microvesicles in metabolic syndrome and renovascular diseaseR01DK102325 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2015 to 2018
$2.8M
Obesity-induced mesenchymal stem cell senescenceR01DK120292 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2019 to 2022
$2.6M
Quantitative magnetization transfer MRI for evaluation of renal fibrosisR01DK122734 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2020 to 2023
$2.2M
Mesenchymal stem cell senescence in diabetic nephropathy (K23 COVID Admin Supplement)K23DK109134 · NIDDK · MAYO CLINIC ROCHESTER · PI HICKSON, LATONYA J · 2016 to 2021
$1.0M
NIA NIH HHS P01 AG062413NIA NIH HHS R37 AG013925NIDDK NIH HHS K23 DK109134NIDDK NIH HHS R01 DK102325NIDDK NIH HHS R01 DK120292NIDDK NIH HHS R01 DK122734NIDDK NIH HHS T32 DK007013
6 · The paper itself

Abstract

backgroundChronic inflammatory conditions like obesity may adversely impact the biological functions underlying the regenerative potential of mesenchymal stromal/stem cells (MSC). Obesity can impair MSC function by inducing cellular senescence, a growth-arrest program that transitions cells to a pro-inflammatory state. However, the effect of obesity on adipose tissue-derived MSC in human subjects remains unclear. We tested the hypothesis that obesity induces senescence and dysfunction in human MSC.

methodsMSC were harvested from abdominal subcutaneous fat collected from obese and age-matched non-obese subjects (

resultsMean age was 59 ± 8 years, 66% were females. Obese subjects had higher body-mass index (BMI) than non-obese. MSC from obese subjects exhibited lower proliferative capacities than non-obese-MSC, suggesting decreased function, whereas their migration remained unchanged. Senescent cell burden and phenotype, manifested as

conclusionHuman obesity triggers an early senescence program in adipose tissue-derived MSC. Thus, obesity-induced cellular injury may alter efficacy of this endogenous repair system and hamper the feasibility of autologous transplantation in obese individuals.

Indexed as

adipose tissuecellular dysfunctioncellular senescencemesenchymal stem cellsobesity

Identifiers

PMID32274385
PMCPMC7113401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.